Skip to main content
Premium Trial:

Request an Annual Quote

Bulldog Bio to Market Dualsystems' Protein Expression Wares in the US

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bulldog Bio this week announced a deal to sell Dualsystems Biotech's protein expression and analysis systems and products in the US.

Bulldog Bio said the deal is a "long-term relationship," and makes it the single source of all Dualsystems' products in the US, but it didn't provide any additional terms of the deal.

Dualsystems is a contract research organization based in Zurich, Switzerland and provides yeast two-hybrid screening services and products and other technologies for protein-related research, as well as custom cDNA library construction services, according to its website.

Bulldog is based in Portsmouth, NH, and provides laboratory products to life science researchers.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.